Abstract | PURPOSE: METHODS: RESULTS: The anxiety level of the spongostan group was lower than that of the control group and the difference was statistically significant at all time intervals (1, 6, 12, 18, 24, 30, 36 and 48 h, p < 0.001, respectively). Postpartum depression rate again was significantly lower in the spongostan group both on postoperative day 2 and day 9 (p ≤ 0.01). All satisfaction scores were significantly higher in the spongostan group than in the control group (p < 0.001). Additionally, first breast-feeding and first mobilization times were significantly shorter and opioid consumption was lower in the spongostan group (p < 0.001). CONCLUSION:
|
Authors | Serap Simavli, Ikbal Kaygusuz, Hasan Kafali |
Journal | Archives of gynecology and obstetrics
(Arch Gynecol Obstet)
Vol. 290
Issue 2
Pg. 249-56
(Aug 2014)
ISSN: 1432-0711 [Electronic] Germany |
PMID | 24639290
(Publication Type: Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Analgesics, Opioid
- Anesthetics, Local
- Fibrin Foam
- Bupivacaine
|
Topics |
- Adolescent
- Adult
- Analgesics, Opioid
(administration & dosage)
- Anesthesia, General
- Anesthetics, Local
(administration & dosage)
- Anxiety
(epidemiology, prevention & control)
- Bupivacaine
(administration & dosage)
- Cesarean Section
(psychology)
- Depression, Postpartum
(epidemiology, prevention & control)
- Double-Blind Method
- Female
- Fibrin Foam
- Humans
- Pain Measurement
- Patient Satisfaction
- Postoperative Care
- Postpartum Period
- Pregnancy
- Prospective Studies
- Turkey
(epidemiology)
- Wound Healing
(drug effects)
|